IDENTIFICATION OF ANTI-SARS-COV-2 AGENTS BASED ON FLAVOR/FRAGRANCE COMPOSITIONS THAT INHIBIT THE INTERACTION BETWEEN THE VIRUS RECEPTOR BINDING DOMAIN AND HUMAN ANGIOTENSIN CONVERTING ENZYME 2.

Identification of anti-SARS-CoV-2 agents based on flavor/fragrance compositions that inhibit the interaction between the virus receptor binding domain and human angiotensin converting enzyme 2.

Coronavirus disease 2019 (COVID-19) pandemic poses a threat to human beings and numerous cases of infection as well as millions of victims have been reported.The binding of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein receptor binding domain (RBD) to human angiotensin converting enzyme 2 (hACE2) is known to promote

read more